0001193805-17-001422.txt : 20170804
0001193805-17-001422.hdr.sgml : 20170804
20170804182353
ACCESSION NUMBER: 0001193805-17-001422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170802
FILED AS OF DATE: 20170804
DATE AS OF CHANGE: 20170804
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEFF JONATHAN S
CENTRAL INDEX KEY: 0001215242
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 171009716
MAIL ADDRESS:
STREET 1: C/O DEERFIELD MANAGEMENT COMPANY, L.P
STREET 2: 780 THIRD AVENUE, 37TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-0102
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
e616444_4-proteon.xml
OWNERSHIP DOCUMENT
X0306
4
2017-08-02
0
0001359931
PROTEON THERAPEUTICS INC
PRTO
0001215242
LEFF JONATHAN S
C/O PROTEON THERAPEUTICS, INC.
WALTHAM
MA
02451
1
0
0
0
Stock Option (Right to Buy)
1.30
2017-08-02
4
A
0
13333
0
A
2027-08-01
Common Stock
13333
13333
D
The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities. The Reporting Person holds the option for the benefit, and at the direction, of Deerfield Management Company, L.P.
The option shall vest and become exercisable with respect to one-third of the shares on each of August 2, 2018, August 2, 2019 and August 2, 2020.
/s/ Jonathan S Leff
2017-08-04